Pharmaceutical industry
The latest news relating to the pharmaceuticals industry, including regulation, litigation, business news and relevant industrial and academic research, from the Royal Society of Chemistry's magazine, Chemistry World
-
BusinessUK loses life sciences investment as pharma companies halt expansion plans
Industry seeks greater share of healthcare spending to support innovation
-
BusinessIndian chemist dies after methanol inhalation incident
Preliminary investigation highlights lack of protective equipment
-
WebinarIon suppression correction and normalisation in metabolomics
Join us on 5 November to learn new ways to improve data consistency with mass spectrometry
-
OpinionLiver toxicity remains an unpredictable hurdle for medicinal chemists
The liver’s complex role in metabolising drugs makes it both a critical consideration and potential stumbling block
-
OpinionDeadly fentanyl contamination exposes drug safety challenges
Bacterial conatmination in medical fentanyl has killed at least 51 people in Argentina, highlighting pressures on generic drugmakers
-
WebinarLipidomics for antibiotic resistance (AMR) mechanisms
Join us on 23 October to discover how microbial antibiotic exposure triggers lipidomic changes, offering insight into how lipids contribute to resistance mechanisms
-
BusinessPharma sector jolted by unpredictable US tariffs policy
Firms face tough decisions amid Trump’s threatened taxes on pharmaceutical imports and ‘capricious’ approach to tariffs
-
BusinessAt least 51 deaths in Argentina linked to tainted medical fentanyl
Investigation reveals history of regulatory failures as pharmaceutical company faces criminal charges over Argentina’s deadliest drug contamination scandal
-
BusinessFour dead after nitrogen leak at pharma factory in India
Incident at Medley Pharmaceuticals’ Boisar–Tarapur plant leaves two others in a serious condition
-
BusinessWill oral weight loss drugs challenge injectables?
Pills may offer convenience for manufacturers, but it’s not clear they will overtake existing drugs
-
BusinessThe challenge of developing oral alternatives to peptide weight loss drugs
Companies are racing to develop alternatives to injectable diabetes and weight loss drugs
-
NewsUS government cancels mRNA vaccine research
Experts fear industrial and academic research may move abroad after infectious disease projects cancelled
-
Opinion‘Creative destruction’ in the chemistry lab
Some obsolete lab equipment is quickly replaced, while other items are stubbornly persistent. What modern tech will survive to the 2060s?
-
BusinessMerck & Co to cut 6000 jobs, Moderna to cut around 500
Both firms aiming to make significant reductions in annual costs by reorganising
-
OpinionIntergovernmental panel on chemicals, waste and pollution needs diverse input
Balancing industrial expertise against unwanted commercial influence is not easy but shouldn’t be discounted
-
ResearchTen years on, pharma industry still testing for implausible alkyl sulfonate ester contaminants
Risk assessment for potential mutagenic side-products is still required by regulatory bodies, despite lack of evidence they form during drug production
-
NewsAs AI-designed drug looks to pass final hurdle, will this tech change drug discovery forever?
AI-led drug for chronic lung disease set to enter phase 3 clinical trials, though experts remain divided on AI’s impact in pharma
-
BusinessSarepta gene therapy deaths highlight tragic rare disease dilemma
Regulators block Duchenne muscular dystrophy treatment after fatal side-effects outweigh questionable efficacy
-
OpinionChina’s drug development charge
Reforms and state support have fuelled domestic and foreign investment in pharmaceutical
-
WebinarWomen’s health: insights in research and inclusion
Learn about the history and importance of the gender gap currently impacting women’s health sciences